BSE Live
Dec 31, 16:01Prev. Close
0.82
Open Price
0.83
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Prev. Close
Open Price
Bid Price (Qty.)
()
Offer Price (Qty.)
()
| Cash Flow of Remedium Lifecare (in Rs. Cr.) | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 | |
| 12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
| Net Profit/Loss Before Extraordinary Items And Tax | 0.00 | 50.45 | 7.40 | 1.53 | 0.65 | |
| Net CashFlow From Operating Activities | 0.00 | -74.16 | 20.50 | 11.28 | -10.21 | |
| Net Cash Used In Investing Activities | 0.00 | 0.00 | -0.04 | -0.05 | -0.04 | |
| Net Cash Used From Financing Activities | 0.00 | 53.83 | -0.04 | -10.61 | 10.14 | |
| Foreign Exchange Gains / Losses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Adjustments On Amalgamation Merger Demerger Others | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Inc/Dec In Cash And Cash Equivalents | 0.00 | -20.33 | 20.42 | 0.62 | -0.11 | |
| Cash And Cash Equivalents Begin of Year | 0.00 | 21.86 | 1.44 | 0.81 | 0.93 | |
| Cash And Cash Equivalents End Of Year | 0.00 | 1.52 | 21.86 | 1.44 | 0.81 |
27.11.2025
Remedium Lifeca Standalone September 2025 Net Sales at Rs 8.58 crore, down 65.8% Y-o-Y
05.08.2025
Remedium Lifeca Standalone June 2025 Net Sales at Rs 18.37 crore, down 76.35% Y-o-Y
24.06.2025
Remedium Lifeca Standalone March 2025 Net Sales at Rs 81.57 crore, down 94.21% Y-o-Y
26.11.2024
Remedium Lifeca Standalone September 2024 Net Sales at Rs 25.08 crore, down 94.65% Y-o-Y
27.11.2025
Remedium Lifeca Standalone September 2025 Net Sales at Rs 8.58 crore, down 65.8% Y-o-Y
05.08.2025
Remedium Lifeca Standalone June 2025 Net Sales at Rs 18.37 crore, down 76.35% Y-o-Y
24.06.2025
Remedium Lifeca Standalone March 2025 Net Sales at Rs 81.57 crore, down 94.21% Y-o-Y
26.11.2024
Remedium Lifeca Standalone September 2024 Net Sales at Rs 25.08 crore, down 94.65% Y-o-Y
15.02.2017
15.02.2017
14.02.2017
13.02.2017